Trial intelligence / Profile preview

Docetaxel and Prednisolone +/- ADT in CRPC

NCT01487902Phase 2Unknown

Sponsor
Asan Medical Center
Start
Jul 2010
Primary completion
Oct 2013
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of leuprolide in prostate cancer (PCa), sponsored by Asan Medical Center. Status: unknown.

02

Drugs

leuprolide
03

Conditions

prostate cancer (PCa)

Beyond the preview

Go deeper on NCT01487902.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01487902.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call